Sickle Cell Disease for Health Professionals
See also
Information for Health Consumers
Clinical Practice Guidelines
The IOM (2011) defined clinical practice guidelines as "statements that include recommendations intended to optimize patient care that are informed by a systematic review of evidence and an assessment of the benefits and harms of alternative care options."
NHLBI Publications and Fact Sheets
RELATED NEWS
|
Research Feature
The coronavirus pandemic has caused tragedy and turmoil for millions of people around the world, but it has been particularly unkind to one group whose health journey is often overlooked: Those with sickle cell disease. A growing number of studies now suggest that people with this painful genetic blood disorder who also are infected with SARS-CoV-2, the virus that causes COVID-19 disease, are more vulnerable to severe health complications than the rest of the population. They also have higher death rates. It is why more than ever, health experts say, people with sickle cell disease need to be...
RELATED EVENT
Virtual
This Sickle Cell Disease Awareness Month, the National Heart, Lung, and Blood Institute (NHLBI), in partnership wit...